Conference
Canadian Cancer Trials Group (CCTG) LY.17: A Randomized Phase II Study Evaluating Novel Salvage Therapy Pre-Autologous Stem Cell Transplant (ASCT) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (RR-DLBCL) - Outcome of Rituximab-Dose-Intensive Cyclophosphamide, Etoposide, Cisplatin (R-DICEP) Versus R-GDP
Authors
Stewart DA; Shepherd LE; Dudebout JJ; Larouche J-F; Chua N; Baetz T; Crump M; Shafey M; Abdel-Samad N; Robinson S
Volume
140
Pagination
pp. 3734-3736
Publisher
American Society of Hematology
Publication Date
November 15, 2022
DOI
10.1182/blood-2022-163706
Conference proceedings
Blood
Issue
Supplement 1
ISSN
0006-4971